Breaking News Novan (NASDAQ: NOVN) Drops Hard After Molluscum Contagiosum Trial Failed To Meet Primary Endpoints Novan Inc. (NASDAQ: NOVN) was a big loser in Friday’s trading session. The stock gapped down and closed the day at a loss of 73.05%. This followed its announcement that, efficacy results from its Phase 3B program dubbed SIMPLE had not met
NASDAQ: SBPH Spring Bank Pharmaceuticals (NASDAQ: SBPH) Drops After Halting Its Phase 2b CATALYST Trials Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH) was one of the biggest losers in post-Christmas trading. The stock dropped by 66.76% to close the day at $1.20. This followed news that the company had stopped taking in patients for its phase 2b CATALYST
Cheap Stocks Correvio Pharma Corp (NASDAQ: CORV) Gets Hit Hard After FDA Comment on Brinavess Correvio Pharma Corp (NASDAQ: CORV) was one of the biggest losers in Friday’s session. It gapped down and closed the day with a loss of 39.81%. This followed news that FDA staffers had stated the benefits of the company’s heart treatment
Cheap NASDAQ Stocks Aldeyra Therapeutics (NASDAQ: ALDX) Gaps Down After Dry Eye Treatment Fails To Meet Goals Aldeyra Therapeutics Inc (NASDAQ: ALDX) was one of the big stock losers in Tuesday’s trading session. The company closed the day at a loss of 32.44%. This followed news that investors were questioning the company’s dry eye treatment. This came after
NYSE: NNVC NanoViricides, Inc (NYSE: NNVC) Gaps Down Even as Shorts Drop NanoViricides, Inc (NYSE: NNVC) closed lower in Friday’s trading session. However, the number of shorts on this stock has declined. In November, short interest stood at 137,100 shares, a 6.5% when compared to October when the number of shorts stood
Losing Stocks Paringa Resources Limited (NASDAQ: PNRL) Eases Up after a Massive Rally Paringa Resources Limited (NASDAQ: PNRL) was one of the biggest losers in yesterday’s trading session. The stock lost by 57.88% to close the day at $3.01. This drop came after it rallied from lows of $1 to over $8 in Thursday’